Astrana Health (ASTH) Stock Looks Fully Valued Following Its 87% Run
2 Reasons to Like ASTH and 1 to Stay Skeptical
Astrana Health, Inc. Schedules 2026 Second Quarter Financial Results Release and Conference Call
TD Cowen Maintains Buy on Astrana Health, Raises Price Target to $50
BTIG Maintains Buy on Astrana Health, Raises Price Target to $65
Astrana Health Strengthens Leadership Team to Accelerate Long-Term Growth
Astrana Health ACOs Deliver $120.4 Million in Gross Shared Savings in 2024 Performance Year
Astrana Health (NASDAQ:ASTH) Screens as a Powerful Minervini Trend Template Stock with High Growth Momentum
Astrana Health (ASTH) Gets Upgraded by Barclays
Astrana Health Named to the 2026 Fortune 1000 List Following Strong Revenue Growth
BTIG Reiterates Buy on Astrana Health, Maintains $50 Price Target
A Look Back at Healthcare Technology for Providers Stocks’ Q1 Earnings: Astrana Health (NASDAQ:ASTH) Vs The Rest Of The Pack
Barclays Upgrades Astrana Health to Overweight, Raises Price Target to $50
Is Astrana’s Q1 Results and AI Platform Push Altering The Investment Case For Astrana Health (ASTH)?
5 Revealing Analyst Questions From Astrana Health’s Q1 Earnings Call
Baird Lifts PT on Astrana Health (ASTH) Following Q1 Results
Truist Securities Maintains Buy on Astrana Health, Raises Price Target to $47
Astrana Health Says Prospect Deal Is Ahead of Schedule as Q1 Trends Beat Expectations
Astrana Health, Inc. (ASTH) Presents at Bank of America Global Healthcare Conference 2026 Transcript
TD Cowen Maintains Buy on Astrana Health, Raises Price Target to $45
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.